Rapid Micro Biosystems In...

2.53
-0.24 (-8.66%)
At close: Apr 03, 2025, 3:59 PM
2.51
-0.79%
After-hours: Apr 03, 2025, 07:31 PM EDT

Rapid Micro Biosystems Statistics

Share Statistics

Rapid Micro Biosystems has 43.24M shares outstanding. The number of shares has increased by 0.87% in one year.

Shares Outstanding 43.24M
Shares Change (YoY) 0.87%
Shares Change (QoQ) 0.47%
Owned by Institutions (%) 27.36%
Shares Floating 22.8M
Failed to Deliver (FTD) Shares 1.76K
FTD / Avg. Volume 0.32%

Short Selling Information

The latest short interest is 113.59K, so 0.26% of the outstanding shares have been sold short.

Short Interest 113.59K
Short % of Shares Out 0.26%
Short % of Float 0.48%
Short Ratio (days to cover) 0.96

Valuation Ratios

The PE ratio is -0.84 and the forward PE ratio is -1.83. Rapid Micro Biosystems's PEG ratio is 0.07.

PE Ratio -0.84
Forward PE -1.83
PS Ratio 1.4
Forward PS 1.9
PB Ratio 0.52
P/FCF Ratio -0.86
PEG Ratio 0.07
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Rapid Micro Biosystems.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.61, with a Debt / Equity ratio of 0.08.

Current Ratio 4.61
Quick Ratio 3.46
Debt / Equity 0.08
Debt / EBITDA -0.12
Debt / FCF -0.14
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $172.09K
Profits Per Employee $-287.66K
Employee Count 163
Asset Turnover 0.29
Inventory Turnover 1.04

Taxes

Income Tax 22K
Effective Tax Rate -0.05%

Stock Price Statistics

The stock price has increased by 185.45% in the last 52 weeks. The beta is 1.1, so Rapid Micro Biosystems's price volatility has been higher than the market average.

Beta 1.1
52-Week Price Change 185.45%
50-Day Moving Average 2.58
200-Day Moving Average 1.32
Relative Strength Index (RSI) 55.79
Average Volume (20 Days) 545.1K

Income Statement

In the last 12 months, Rapid Micro Biosystems had revenue of 28.05M and earned -46.89M in profits. Earnings per share was -1.08.

Revenue 28.05M
Gross Profit 7.01M
Operating Income -49.92M
Net Income -46.89M
EBITDA -49.92M
EBIT -49.92M
Earnings Per Share (EPS) -1.08
Full Income Statement

Balance Sheet

The company has 16.91M in cash and 6.17M in debt, giving a net cash position of 10.74M.

Cash & Cash Equivalents 16.91M
Total Debt 6.17M
Net Cash 10.74M
Retained Earnings -475.27M
Total Assets 98.17M
Working Capital 63.35M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -44.15M and capital expenditures -1.36M, giving a free cash flow of -45.52M.

Operating Cash Flow -44.15M
Capital Expenditures -1.36M
Free Cash Flow -45.52M
FCF Per Share -1.04
Full Cash Flow Statement

Margins

Gross margin is 24.99%, with operating and profit margins of -177.96% and -167.16%.

Gross Margin 24.99%
Operating Margin -177.96%
Pretax Margin -167.08%
Profit Margin -167.16%
EBITDA Margin -177.96%
EBIT Margin -177.96%
FCF Margin -162.27%

Dividends & Yields

RPID does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for RPID is $8, which is 192% higher than the current price. The consensus rating is "Buy".

Price Target $8
Price Target Difference 192%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score -4.42
Piotroski F-Score 4